Evolutionary Medical Genomics Doctoral Network

HORIZON.1.2HORIZON-TMA-MSCA-DNID: 101226544
EC Contribution
โ‚ฌ46,014
Consortium Size
22 orgs
โ–ถSummary

The Evolutionary Medical Genomics Doctoral Network (EvoMG-DN) pioneers an integrative approach combining Evolutionary Medicine and Medical Genomics to address critical health challenges. By combining evolutionary insights with state-of-the-art genomic tools, EvoMG-DN seeks to establish EvoMG as a structured and impactful discipline in Europe. The network aims to train the next generation of interdisciplinary researchers to unlock the full potential of evolutionary genomic approaches in healthcare.EvoMG-DN pursues three overarching objectives: (i) foster interdisciplinary synergy by uniting EvoMG researchers from diverse fields to catalyze innovation in methodologies and tools; (ii) create a cohesive training framework, equipping doctoral candidates (DCs) with expertise in EvoMG applications through structured training and collaboration; and (iii) advance evolution-informed clinical applications, such as adaptive cancer therapies.The research program is organized into three scientific work packages: WP1 explores evolutionary insights into ageing and age-related diseases; WP2 focuses on tumor evolution and acquisition of resistance in cancer therapies; and WP3 addresses pathogen evolution, antibiotic resistance and interactions with the immune system. These are underpinned by core methodological pillars, which include comparative functional genomics, genetic diversity analysis, mathematical modeling and machine learning, and the use of unconventional model organisms.Through interdisciplinary secondments, tailored mentoring, and advanced training modules, EvoMG-DN empowers DCs to bridge disciplines and develop actionable solutions to global health challenges. By formalizing EvoMG methodologies and advancing clinical applications, EvoMG-DN aims to solidify Europeโ€™s leadership in biomedical research and deliver long-lasting societal impact.

Consortium (22)

๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO CENTRE DE REGULACIO GENOMICAES
coordinator
๐Ÿ‡ช๐Ÿ‡ธ BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACIONES
partner
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
partner
๐Ÿ‡ธ๐Ÿ‡ช CHALMERS TEKNISKA HOGSKOLA ABSE
partner
๐Ÿ‡บ๐Ÿ‡ธ DUKE UNIVERSITYUS
partner
๐Ÿ‡ซ๐Ÿ‡ท ECOLE NORMALE SUPERIEUREFR
partner
๐Ÿ‡จ๐Ÿ‡ญ EUROPEAN MOLECULAR BIOLOGY ORGANIZATIONCH
partner
๐Ÿ‡ต๐Ÿ‡น FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOAPT
partner
๐Ÿ‡ฉ๐Ÿ‡ช FRIEDRICH-SCHILLER-UNIVERSITร„T JENADE
partner
๐Ÿ‡ต๐Ÿ‡น FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINEPT
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO D'ESTUDIS I RECERCA ONCOLOGICA (FERO)ES
partner
๐Ÿ‡ซ๐Ÿ‡ท INSTITUT PASTEURFR
partner
๐Ÿ‡ฌ๐Ÿ‡ง INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBGGB
partner
๐Ÿ‡ฉ๐Ÿ‡ช LEIBNIZ-INSTITUT FUR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT EV (FLI) LEIBNIZ INSTITUTE ON AGING - FRITZ LIPMANN INSTITUTE EV (FLI)DE
partner
๐Ÿ‡ฌ๐Ÿ‡ง Mashauri LimitedGB
partner
๐Ÿ‡ช๐Ÿ‡ธ Microomics Systems S.L.ES
partner
๐Ÿ‡ฌ๐Ÿ‡ง Nonacus LtdGB
partner
๐Ÿ‡ฌ๐Ÿ‡ง THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGEGB
partner
๐Ÿ‡ช๐Ÿ‡ธ UNIVERSIDAD POMPEU FABRAES
partner
๐Ÿ‡ช๐Ÿ‡ธ UNIVERSITAT DE BARCELONAES
partner
๐Ÿ‡ซ๐Ÿ‡ท UNIVERSITE PARIS CITEFR
partner
๐Ÿ‡ฎ๐Ÿ‡ช UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINIE
partner